Astrazeneca Covid-19 vaccine

This is the first COVID-19 vaccine licensed by the Ministry of Health for immunization to prevent COVID-19 caused by the coronavirus SARS-CoV-2 in Vietnam.

According to Minister of Health Nguyen Thanh Long, Astra Zeneca pledged to supply about 30 million doses of vaccine to Vietnam in 2021.

The ministry is working with other partners to increase the number of vaccines for Vietnam.

Astra Zeneca’s COVID-19 vaccine is expected to be available and injected into Vietnamese people in the first quarter of this year.

AstraZeneca COVID-19 vaccine was co-invented by the UK’s University of Oxford and its spin-out company AstraZeneca. This vaccine is recommended for people aged between 18 – 64.

The ministry has also directed domestic vaccine producers to urgently conduct vaccine research, clinical trials and production.

The ministry said that Nanogen Pharmaceutical Biotechnology JSC (Nanogen) has completed the first phase of clinical trial of Nanocovax vaccine in the first phase, and it will carry out the second phase of trial in early February.

Meanwhile, the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang city began the first phase of trial for Covivac vaccine on January 21.

Thuy Hanh

Vietnam’s second COVID-19 vaccine candidate enters human trials

A ceremony was held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC, Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants.